Efficacy and safety of intravenous captopril in congestive heart failure
Authors:
- K. LangesKLK. Langes
- J. SiebelsJSJ. Siebels
- K.H. KuckKKK.H. Kuck
- 28 February 1993
- journal article
- Published by Elsevier in Current Therapeutic Research
- Vol. 53 (2) , 167-176
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Impact of converting enzyme inhibition on progression of chronic heart failure: results of the Munich Mild Heart Failure Trial.Heart, 1992
- Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart FailureNew England Journal of Medicine, 1991
- Comparative Effects of Therapy With Captopril and Digoxin in Patients With Mild to Moderate Heart FailureJAMA, 1988
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987
- Comparison of Captopril and Enalapril in Patients with Severe Chronic Heart FailureNew England Journal of Medicine, 1986
- Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart FailureNew England Journal of Medicine, 1986
- Intravenous captopril treatment in patients with severe cardiac failure.Heart, 1986
- Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state.Heart, 1985
- A placebo-controlled trial of captopril in refractory chronic congestive heart failureJACC, 1983
- Angiotensin converting enzyme inhibition in patients with congestive heart failure.Circulation, 1978